CYP1B1, VEGFA, BCL2, and CDKN1A Affect the Development of Chronic Obstructive Pulmonary Disease

References

• MirzaS, BenzoR. Chronic obstructive pulmonary disease phenotypes: implications for care. Mayo Clin Proc. 2017;92(7):1104–1112. doi:10.1016/j.mayocp.2017.03.02028688465
   PubMed Web of Science ®Google Scholar
• BringsvorHB, SkaugK, LangelandE, et al. Symptom burden and self-management in persons with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2018;13:365–373. doi:10.2147/COPD.S15142829416327
   PubMed Web of Science ®Google Scholar
• MohammedJ, DeromE, DeWI, RambautL, CaldersP. Autonomic symptoms in patients with moderate and severe chronic obstructive pulmonary disease. Acta Clin Belg. 2018;73(3):182–190. doi:10.1080/17843286.2017.137925528934906
   PubMed Web of Science ®Google Scholar
• de TorresJP, CelliBR. Is chronic obstructive pulmonary disease really a progressive disease? Arch Bronconeumol. 2016;53(7):632–636.
   Web of Science ®Google Scholar
• RuttenFH, HoesAW. Chronic obstructive pulmonary disease: a slowly progressive cardiovascular disease masked by its pulmonary effects? Eur J Heart Fail Suppl. 2014;14(4):348–350. doi:10.1093/eurjhf/hfs022
   Google Scholar
• WangX, LiW, ZhangY, et al. Chronic obstructive pulmonary disease candidate gene prioritization based on metabolic networks and functional information. PLoS One. 2017;12(9):e0184299. doi:10.1371/journal.pone.018429928873096
   PubMed Web of Science ®Google Scholar
• SilvaBSDA, LiraFS, RossiFE, et al. Inflammatory and metabolic responses to different resistance training on chronic obstructive pulmonary disease: a randomized control trial. Front Physiol. 2018;9:262. doi:10.3389/fphys.2018.0026229628896
   PubMed Web of Science ®Google Scholar
• VosT, AllenC, AroraM, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the global burden of disease study 2015. Lancet. 2016;388(10053):1545–1602. doi:10.1016/S0140-6736(16)31678-627733282
   PubMed Web of Science ®Google Scholar
• NiK, ZhaoZH, ZhangJQ, et al. Study on relationship between pleomorphic adenoma gene-like 2 and chronic obstructive pulmonary disease. Nanosci Nanotechnol Lett. 2017;9(7):1009–1014. doi:10.1166/nnl.2017.2420
   Web of Science ®Google Scholar
• ZhouL, YingL, XinC, et al. Over-expression of nuclear factor-κb family genes and inflammatory molecules is related to chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2018;13:2131–2138. doi:10.2147/COPD.S16415130034228
   PubMed Web of Science ®Google Scholar
• GagliardoR, ChanezP, ProfitaM, et al. Iκb kinase–driven nuclear factor-κb activation in patients with asthma and chronic obstructive pulmonary disease. J Allergy Clin Immunol. 2011;128(3):635–645.e632. doi:10.1016/j.jaci.2011.03.04521571356
   PubMed Web of Science ®Google Scholar
• DagouassatM, GaglioloJM, ChruscielS, et al. The cyclooxygenase-2-prostaglandin e2 pathway maintains senescence of chronic obstructive pulmonary disease fibroblasts. Am J Respir Crit Care Med. 2013;187(7):703–714. doi:10.1164/rccm.201208-1361OC23328527
   PubMed Web of Science ®Google Scholar
• NofzigerC, VezzoliV, DossenaS, et al. Stat6 links il-4/il-13 stimulation with pendrin expression in asthma and chronic obstructive pulmonary disease. Clin Pharmacol Ther. 2011;90(3):399–405. doi:10.1038/clpt.2011.12821814192
   PubMed Web of Science ®Google Scholar
• Willis-OwenSA, ThompsonA, KempPR, et al. Copd is accompanied by co-ordinated transcriptional perturbation in the quadriceps affecting the mitochondria and extracellular matrix. Sci Rep. 2018;8(1):12165. doi:10.1038/s41598-018-29789-630111857
   PubMed Web of Science ®Google Scholar
• GautierL, Cope LBolstadBM, IrizarryRA. Affy - analysis of affymetrix genechip data at the probe level. Bioinformatics. 2004;20:307–315. doi:10.1093/bioinformatics/btg40514960456
   PubMed Web of Science ®Google Scholar
• IrizarryRA, BridgetH, FrancoisC, et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics. 2003;4(2):249–264. doi:10.1093/biostatistics/4.2.24912925520
   PubMed Web of Science ®Google Scholar
• RitchieME, BelindaP, DiW, et al. Limma powers differential expression analyses for rna-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47. doi:10.1093/nar/gkv00725605792
   PubMed Web of Science ®Google Scholar
• PengL, TongT. A note on a two-sample test with one variance unknown. Stat Methodol. 2011;8(6):528–534. doi:10.1016/j.stamet.2011.07.001
   Google Scholar
• CaiQ, ChanHP. A double application of the benjamini-hochberg procedure for testing batched hypotheses. Methodol Comput Appl Probab. 2016;19(2):1–15.
   Web of Science ®Google Scholar
• DaWH, ShermanBT, LempickiRA. Systematic and integrative analysis of large gene lists using david bioinformatics resources. Nat Protoc. 2009;4(1):44–57. doi:10.1038/nprot.2008.21119131956
   PubMed Web of Science ®Google Scholar
• BalakrishnanR, HarrisMA, HuntleyR, AukenKV, CherryJM. A guide to best practices for gene ontology (go) manual annotation. Database. 2013;2013(1):2681–2694. doi:10.1093/database/bat054
   Google Scholar
• KlukasC, SchreiberF. Dynamic exploration and editing of kegg pathway diagrams. Bioinformatics. 2007;23(3):344. doi:10.1093/bioinformatics/btl61117142815
   PubMed Web of Science ®Google Scholar
• Allan PeterD, GrondinCJ, KelleyLH, et al. The comparative toxicogenomics database’s 10th year anniversary: update 2015. Nucleic Acids Res. 2015;43(Database issue):914–920. doi:10.1093/nar/gku935
   Web of Science ®Google Scholar
• JianguoX, SinelnikovIV, BeomsooH, WishartDS. Metaboanalyst 3.0–making metabolomics more meaningful. Nucleic Acids Res. 2015;43(W1):W251. doi:10.1093/nar/gkv38025897128
   PubMed Web of Science ®Google Scholar
• GaujouxR, SeoigheC. A flexible r package for nonnegative matrix factorization. BMC Bioinformatics. 2010;11(1):367. doi:10.1186/1471-2105-11-36720598126
   PubMed Web of Science ®Google Scholar
• HoJH, ShihHC, LiaoBY, ChuSC. A ladder diffusion algorithm using ant colony optimization for wireless sensor networks. Inf Sci. 2012;192(6):204–212. doi:10.1016/j.ins.2011.03.013
   Web of Science ®Google Scholar
• PanP, NakashimaM, TomofujiH. Online test using displacement–force mixed control. Earthq Eng Struct Dyn. 2010;34(8):869–888. doi:10.1002/eqe.457
   Web of Science ®Google Scholar
• KamataS, FujinoN, YamadaM, et al. Expression of cytochrome p450 mrnas in type ii alveolar cells from subjects with chronic obstructive pulmonary disease. Pharmacol Res Perspect. 2018;6(3):e00405. doi:10.1002/prp2.40529850024
   PubMed Web of Science ®Google Scholar
• HukkanenJ, PelkonenO, HakkolaJ, RaunioH. Expression and regulation of xenobiotic-metabolizing cytochrome p450 (cyp) enzymes in human lung. Crit Rev Toxicol. 2002;32(5):391–411. doi:10.1080/2002409106427312389869
   PubMed Web of Science ®Google Scholar
• AcquaahmensahGK, MalhotraD, VulimiriM, McdermottJE, BiswalS. Suppressed expression of t-box transcription factors is involved in senescence in chronic obstructive pulmonary disease. PLoS Comput Biol. 2012;8(7):e1002597. doi:10.1371/journal.pcbi.100259722829758
   PubMed Web of Science ®Google Scholar
• LakhdarR, DrostEM, MacneeW, BastosR, RabinovichRA. 2d-dige proteomic analysis of vastus lateralis from copd patients with low and normal fat free mass index and healthy controls. Respir Res. 2017;18(1):81. doi:10.1186/s12931-017-0525-x28468631
   PubMed Web of Science ®Google Scholar
• RabinovichRA, DrostE, ManningJR, et al. Genome-wide mrna expression profiling in vastus lateralis of copd patients with low and normal fat free mass index and healthy controls. Respir Res. 2015;16(1):1. doi:10.1186/s12931-014-0139-525567521
   PubMed Web of Science ®Google Scholar
• IkariJ, NelsonAJ, ObaidJ, et al. Reduced microrna-503 expression augments lung fibroblast vegf production in chronic obstructive pulmonary disease. PLoS One. 2017;12(9):e0184039. doi:10.1371/journal.pone.018403928880936
   PubMed Web of Science ®Google Scholar
• BallaMM, DesaiS, PurwarP, et al. Differential diagnosis of lung cancer, its metastasis and chronic obstructive pulmonary disease based on serum vegf, il-8 and mmp-9. Sci Rep. 2016;6(36065):36065. doi:10.1038/srep3606527811960
   PubMed Web of Science ®Google Scholar
• DorotaKS, TadeuszP, PawelG, HenrykS. Serum vascular endothelial growth factor and its receptor level in patients with chronic obstructive pulmonary disease. Eur Cytokine Netw. 2006;17(1):75–79.16613766
   PubMed Web of Science ®Google Scholar
• Chun GeunL, BingM, SeyedtaghiT, et al. Studies of vascular endothelial growth factor in asthma and chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2011;8(6):512–515. doi:10.1513/pats.201102-018MW22052929
   PubMedGoogle Scholar
• MakotoS, NoriakiT, SumitoI, et al. Intronic single-nucleotide polymorphisms in bcl-2 are associated with chronic obstructive pulmonary disease severity. Respirology. 2010;12(1):34–41.
   Google Scholar
• ZengH, KongX, PengH, et al. Apoptosis and bcl-2 family proteins, taken to chronic obstructive pulmonary disease. Eur Rev Med Pharmacol Sci. 2012;16(6):711–727.22913201
   PubMed Web of Science ®Google Scholar
• WuY, LiY, WuB, et al. Β-arrestin2 inhibits expression of inflammatory cytokines in beas-2b lung epithelial cells treated with cigarette smoke condensate via inhibition of autophagy. Cell Physiol Biochem. 2018;50(4):1270–1285. doi:10.1159/00049458630355935
   PubMedGoogle Scholar